Effect of alendronate on the femoral metaphyseal defect under carbamazepine in ovariectomized rats

Effect of alendronate on the femoral metaphyseal defect under carbamazepine in ovariectomized rats

Abstract Background The use of antiepileptic drugs and estrogen deficiency put forward higher requirements for bone defect regeneration. The present study investigated the effects of alendronate (ALN) on femoral bone defect in ovariectomized (OVX) rats under the influence of carbamazepine (CBZ). Met...

Full description

Bibliographic Details
Main Authors:	Ruotian Zhang, Min Yang, Yang Li, Hedong Liu, Maoxian Ren, Zhou-Shan Tao
Format:	Article
Language:	English
Published:	BMC 2021-01-01
Series:	Journal of Orthopaedic Surgery and Research
Subjects:	Osteoporotic bone defect Alendronate Carbamazepine Regeneration
Online Access:	https://doi.org/10.1186/s13018-020-02151-1

Similar Items

Alendronate loaded graphene oxide functionalized collagen sponge for the dual effects of osteogenesis and anti-osteoclastogenesis in osteoporotic rats
by: Yuyang Zeng, et al.
Published: (2020-12-01)

Aspirin modified strontium-doped β-tricalcium phosphate can accelerate the healing of femoral metaphyseal defects in ovariectomized rats
by: Zhou-Shan Tao, et al.
Published: (2020-12-01)

Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates
by: I. B. Belyaeva, et al.
Published: (2020-08-01)

The Impact of Alendronate on Bone Mineral Density of Osteoporotic Patients
by: Hamidreza Aghaei-Meybodi, et al.
Published: (2013-12-01)

Treatment of Degree II Furcation Defects Using Autogenous Grafts with and without Alendronate - A Split Mouth Clinical Study
by: Sujit Kumar, et al.
Published: (2014-01-01)

Radiodensitometric and DXA analyses for the measurement of bone mineral density after systemic alendronate therapy
by: Marília Pacífico Lucisano, et al.
Published: (2013-06-01)

Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers
by: Anuj SHARMA, et al.

Anti-resorptive effect of Sodium Alendronate and the combination of Alendronate and Atorvastatin in ligature-induced periodontitis in rats. PAULA
by: Paula GÃes Pinheiro Dutra
Published: (2012)

Morphological and histomorphometric evaluation of autogenous bone graft resorption in rabbits treated with alendronate sodium
by: Teo Mario da ROSA, et al.

Efficacy and safety of alendronic acid in the treatment of osteoporosis in children
by: Alberto Martín Siguero, et al.
Published: (2015-11-01)

Alendronate in patients with calcium nephrolithiasis and loss of bone mass
by: Arrabal-Polo Miguel, et al.
Published: (2012-08-01)

Carbamazepine Induced Malformations
by: J Gordon Millichap
Published: (1989-06-01)

The Effect of Alendronate Loaded Biphasic Calcium Phosphate Scaffolds on Bone Regeneration in a Rat Tibial Defect Model
by: Kwang-Won Park, et al.
Published: (2015-11-01)

Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects
by: Veena H, et al.
Published: (2010-01-01)

Vertebral Collapse Prevented Following Teriparatide Treatment in Postmenopausal Kümmell's Disease Patients with Severe Osteoporosis
by: Peng‐guo Gou, et al.
Published: (2021-04-01)

Use of alendronate in the therapy of osteoporosis
by: O. B. Ershova
Published: (2020-01-01)

Spontaneous Subtrochanteric Femoral Stress Fracture Related to Alendronate : A Case Report
by: Paul CC Chew, et al.
Published: (2013-03-01)

The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004-12-01)

Comparison of the effect of alendronate and pamidronate on bone density of patients with osteoporosis
by: Zohre Nobakht, et al.
Published: (2018-12-01)

Effect of 17ß-estradiol or alendronate on the bone densitometry, bone histomorphometry and bone metabolism of ovariectomized rats
by: L.H.B.C. da Paz, et al.
Published: (2001-08-01)

Esophageal ulcer and alendronate
by: Angelo Paulo Ferrari Junior, et al.

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01)

Development and validation of SPE-HPLC method for the determination of carbamazepine and its metabolites carbamazepine epoxide and carbamazepine trans-diol in plasma
by: Spasić Mirjana, et al.
Published: (2012-01-01)

REVIEW OF BASIC CLINICAL TRIALS OF ALENDRONATE
by: E G Zotkin, et al.
Published: (2010-03-01)

The protective role of folic acid on tratogenic effect of Carbamazepine in Balb/c mice
by: Afshar M (PhD), et al.
Published: (2010-09-01)

The Effect of Valproic Acid or Carbamazepine at Bone Metabolism in Epileptic Patients
by: Yılmaz Çetinkaya, et al.
Published: (2014-03-01)

Carbamazepine-Induced Diarrhea
by: J Gordon Millichap
Published: (1992-03-01)

Femoral Shaft Cortical Pathology associated with longterm Alendronate Therapy: A New Classification
by: MK Kwan, et al.
Published: (2013-07-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
by: Chan Kai-Ming, et al.
Published: (2011-07-01)

Pharmacokinetics of alendronate in a combined Alendronate/Vitamin D3 tablet in healthy volunteers using plasma and urine data
by: Chalitpon Na nakorn, et al.
Published: (2013-06-01)

The Findings of Bone Mineral Densitometry Following Preventive Treatment with Alendronate in Menopausal Women with Osteopenia; What is the Best Dose?
by: Mansour Karimifar, et al.
Published: (2020-12-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

Genetic polymorphisms and their influence on therapeutic response to alendronate-a pilot study
by: CIUBEAN Alina Deniza,, et al.
Published: (2019-09-01)

Akermanite used as an alkaline biodegradable implants for the treatment of osteoporotic bone defect
by: Wenlong Liu, et al.
Published: (2016-12-01)

Atypical femoral fracture in the setting of alendronate treatment for osteoporosis: a case report and literature review
by: Eric D. Van Baarsel, et al.
Published: (2019-07-01)

Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis
by: Elma Kučukalić-Selimović, et al.
Published: (2011-02-01)

Irrational use of alendronate sodium by the elderly
by: Camila Pereira Alvim, et al.
Published: (2020-11-01)

Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats
by: Tetsuo Yano, et al.
Published: (2021-06-01)

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats
by: Opeyemi Samson Osuntokun, et al.
Published: (2021-01-01)

Experimental osteonecrosis: development of a model in rodents administered alendronate
by: Nicolau CONTE NETO, et al.